Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.
Megumi OshimaBruce NealTadashi ToyamaToshiaki OhkumaQiang LiDick de ZeeuwHiddo J L HeerspinkKenneth W MahaffeyGregory FulcherWilliam CanovatchelDavid R MatthewsVlado PerkovicPublished in: Journal of the American Society of Nephrology : JASN (2020)
CANagliflozin cardioVascular Assessment Study (CANVAS), NCT01032629 and CANVAS-R, NCT01989754.